Genetics of Complex Traits, College of Medicine and Health, University of Exeter, Exeter, Devon, United Kingdom.
Institute for Molecular Medicine Finland (FIMM), HiLIFE, University of Helsinki, Helsinki, Finland.
PLoS Genet. 2022 Sep 22;18(9):e1010356. doi: 10.1371/journal.pgen.1010356. eCollection 2022 Sep.
Rare variants in ten genes have been reported to cause Mendelian sleep conditions characterised by extreme sleep duration or timing. These include familial natural short sleep (ADRB1, DEC2/BHLHE41, GRM1 and NPSR1), advanced sleep phase (PER2, PER3, CRY2, CSNK1D and TIMELESS) and delayed sleep phase (CRY1). The association of variants in these genes with extreme sleep conditions were usually based on clinically ascertained families, and their effects when identified in the population are unknown. We aimed to determine the effects of these variants on sleep traits in large population-based cohorts. We performed genetic association analysis of variants previously reported to be causal for Mendelian sleep and circadian conditions. Analyses were performed using 191,929 individuals with data on sleep and whole-exome or genome-sequence data from 4 population-based studies: UK Biobank, FINRISK, Health-2000-2001, and the Multi-Ethnic Study of Atherosclerosis (MESA). We identified sleep disorders from self-report, hospital and primary care data. We estimated sleep duration and timing measures from self-report and accelerometery data. We identified carriers for 10 out of 12 previously reported pathogenic variants for 8 of the 10 genes. They ranged in frequency from 1 individual with the variant in CSNK1D to 1,574 individuals with a reported variant in the PER3 gene in the UK Biobank. No carriers for variants reported in NPSR1 or PER2 were identified. We found no association between variants analyzed and extreme sleep or circadian phenotypes. Using sleep timing as a proxy measure for sleep phase, only PER3 and CRY1 variants demonstrated association with earlier and later sleep timing, respectively; however, the magnitude of effect was smaller than previously reported (sleep midpoint ~7 mins earlier and ~5 mins later, respectively). We also performed burden tests of protein truncating (PTVs) or rare missense variants for the 10 genes. Only PTVs in PER2 and PER3 were associated with a relevant trait (for example, 64 individuals with a PTV in PER2 had an odds ratio of 4.4 for being "definitely a morning person", P = 4x10-8; and had a 57-minute earlier midpoint sleep, P = 5x10-7). Our results indicate that previously reported variants for Mendelian sleep and circadian conditions are often not highly penetrant when ascertained incidentally from the general population.
十种基因中的罕见变异已被报道可导致孟德尔睡眠疾病,其特征为睡眠时间或时间极端延长。这些基因包括家族性自然短睡眠(ADRB1、DEC2/BHLHE41、GRM1 和 NPSR1)、提前睡眠阶段(PER2、PER3、CRY2、CSNK1D 和 TIMELSS)和延迟睡眠阶段(CRY1)。这些基因中的变异与极端睡眠状况的关联通常基于临床上确定的家族,而在人群中识别到的这些变异的影响尚不清楚。我们旨在确定这些变体在大型基于人群的队列中对睡眠特征的影响。我们对先前报道为孟德尔睡眠和昼夜节律疾病的因果关系的变体进行了遗传关联分析。分析使用了来自 4 项基于人群的研究(英国生物银行、FINRISK、健康 2000-2001 年和动脉粥样硬化的多民族研究)的 191929 名个体的睡眠数据以及全外显子或基因组序列数据。我们从自我报告、医院和初级保健数据中确定睡眠障碍。我们从自我报告和加速度计数据中估计睡眠持续时间和时间测量值。我们在英国生物银行中鉴定出 10 个基因中的 8 个基因的 10 个先前报道的致病性变异中的 10 个中的 10 个变体的携带者。它们的频率范围从 CSNK1D 中的 1 个个体到英国生物银行中 PER3 基因的 1574 个报告变异。未鉴定到 NPSR1 或 PER2 报告变异的携带者。我们没有发现分析的变体与极端睡眠或昼夜节律表型之间的关联。使用睡眠时间作为睡眠阶段的替代测量值,仅 PER3 和 CRY1 变体分别显示与更早和更晚的睡眠时间相关;然而,效应的幅度小于先前报道的(睡眠中点提前约 7 分钟,晚约 5 分钟)。我们还对 10 个基因的蛋白质截断(PTV)或罕见错义变体进行了负担测试。只有 PER2 和 PER3 中的 PTV 与相关特征相关(例如,PER2 中的 64 个 PTV 个体成为“肯定是早起的人”的可能性比其他个体高 4.4 倍,P = 4x10-8;睡眠中点提前 57 分钟,P = 5x10-7)。我们的结果表明,从一般人群中偶然确定的孟德尔睡眠和昼夜节律疾病的先前报道的变体通常不是高度外显的。